参考文献/References:
[1] Littlejohn EA,Monrad SU.Early diagnosis and treatment of rheumatoid arthritis[J].Primary Care,2018,45(2):237-255.
[2] 李长超,柴艳梅,刘 丹,等.类风湿关节炎患者血清IL-13水平表达及对外周血单个核细胞中Th17细胞亚群分化的影响[J].陕西医学杂志,2021,50(2):197-200.
[3] 朱竹菁,苏 励,田 雨.蠲痹化湿汤治疗女性寒湿型类风湿关节炎临床研究[J].陕西中医,2020,41(5):632-635.
[4] Alam J,Jantan I,Bukhari SNA.Rheumatoid arthritis:Recent advances on its etiology,role of cytokines and pharmacotherapy[J].Biomed Pharmacother,2017,92:615-633.
[5] 梁小弟,梁小菊,李芙蓉,等.Smad核相互作用蛋白1在白细胞介素-1β诱导骨关节炎中的作用及机制实验研究[J].陕西医学杂志,2021,50(4):390-394.
[6] Aass KR,Kastnes MH,Standal T.Molecular interactions and functions of IL-32[J].J Leuko Biol,2021,109(1):143-159.
[7] Amatya N,Garg AV,Gaffen SL.IL-17 Signaling:The yin and the yang[J].Trends Immunol,2017,38(5):310-322.
[8] 赵 芳,王 玉,孟祖东,等.慢性自发性荨麻疹患者血清IL-17、IL-31和IL-33水平检测及临床意义[J].陕西医学杂志,2020,49(8):1035-1039.
[9] Wang X,Wong K,Ouyang W,et al.Targeting IL-10 family cytokines for the treatment of human diseases[J].Cold Spring Harb Perspect Bio,2019,11(2):548.
[10] Tabrizi R,Vakili S,Akbari M,et al.The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress:A systematic review and meta-analysis of randomized controlled trials[J].Phytother Res,2019,33(2):253-262.
[11] Sloot YJE,Smit JW,Joosten LB,et al.Insights into the role of IL-32 in cancer[J].Semin Immunol,2018,38:24-32.
[12] Joosten LA,Netea MG,Kim SH,et al.IL-32,a proinflammatory cytokine in rheumatoid arthritis[J].Proc Natl Acad Sci USA,2006,103(9):3298-3303.
[13] 桂 明,李 英,张 浩,等.类风湿关节炎患者外周血白细胞介素-32的表达及临床意义[J].中华风湿病学杂志,2013,17(2):103-108.
[14] Mcgeachy MJ,Cua DJ,Gaffen SL.The IL-17 family of cytokines in health and disease[J].Immunity,2019,50(4):892-906.
[15] Zhang X,Yuan Y,Pan Z,et al.Elevated circulating IL-17 level is associated with inflammatory arthritis and disease activity:A meta-analysis[J].Clin Chim Acta,2019,496:76-83.
[16] 王婷婷,单 超,赵 今.白细胞介素-17基因多态性与牙周炎和类风湿性关节炎相关性研究进展[J].新乡医学院学报,2020,37(5):104-107.
[17] 李 茜,张国栋,刘 毅,等.IL-17和IRF4在类风湿关节炎中的表达及临床意义[J].西部医学,2016,28(11):1506-1509.
[18] 王小超,陆 翔,陆玉敏,等.类风湿性关节炎早期患者IL-17水平与骨关节损害的相关性研究[J].山东医药,2011,51(1):102-103.
[19] Ip WKE,Hoshi N,Shouval DS,et al.Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages[J].Science,2017,356(6337):513-519.
[20] 黄建军,汤荣华.类风湿关节炎患者血清GM-CSF、IL-6、IL-17和TNF-α的水平测定及临床意义[J].检验医学,2011,28(3):173-177.
[21] 朱 江,高 欣,谢文利,等.京尼平苷对类风湿性关节炎大鼠血清IL-1β和TNF-α的影响[J].中国中药杂志,2005,30(9):708-711.
[22] 张玉玲,张婉婷,曹 干,等.外周血IL-10表达水平在类风湿关节炎诊断中的临床意义[J].黑龙江科技信息,2019,23(32):11-12.
[23] Tian S,Yan Y,Qi X,et al.Treatment of type Ⅱ collagen-induced rat rheumatoid arthritis model by interleukin 10(IL10)-mesenchymal stem cells(BMSCs)[J].Med Sci Monit,2019,25:2923-2934.
[24] 曾繁明.hs-CRP、RF、抗CCP抗体联合检测在类风湿性关节炎诊断中的应用价值分析[J].医药前沿,2020,10(2):139-140.
相似文献/References:
[1]卢北玲,史剑飞,彭 晶,等.CRP、RF及ASO检测在类风湿关节炎合并肺间质纤维化诊断中的价值[J].陕西医学杂志,2019,(6):803.
[2]孙芳芳,张 静△,范秀风.类风湿关节炎合并心血管损伤危险因素研究*[J].陕西医学杂志,2019,(10):1305.
[3]王 颖,白 琳,张 洁,等.抑制炎性细胞因子与类风湿关节炎合并急性心肌梗死患者颈动脉斑块相关性研究*[J].陕西医学杂志,2019,(12):1679.
[4]刘昌莲,贺冬冬,李晓明,等.艾拉莫德治疗类风湿关节炎疗效及对患者免疫炎症因子水平和骨代谢指标的影响*[J].陕西医学杂志,2020,49(5):603.
LIU Changlian,HE Dongdong,LI Xiaoming,et al.Clinical efficacy of Iguratimod in the treatment of rheumatoid arthritis and its effect on the levels of immune inflammatory factors and the indexes of bone metabolism[J].,2020,49(12):603.
[5]刘兆宜,沈洲立,岳跃兵,等.类风湿关节炎并发动脉粥样硬化相关性研究进展*[J].陕西医学杂志,2020,49(11):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
LIU Zhaoyi,SHEN Zhouli,YUE Yuebing,et al.Research progress on the correlation between rheumatoid arthritis and atherosclerosis[J].,2020,49(12):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
[6]李长超,柴艳梅,刘 丹,等.类风湿关节炎患者血清IL-13水平表达及对外周血单个核细胞中Th17细胞亚群分化的影响[J].陕西医学杂志,2021,50(2):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
LI Changchao,CHAI Yanmei,LIU Dan,et al.Expression of serum IL-13 in patients with rheumatoid arthritis and its effect on differentiation of Th17 cell subsets in PBMC[J].,2021,50(12):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
[7]杨 婧,何家锐,孙红兵,等.沙利度胺对类风湿关节炎滑膜细胞及外周血单个核细胞分泌肿瘤坏死因子-α和血管内皮生长因子的影响及机制研究[J].陕西医学杂志,2022,51(12):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
YANG Jing,HE Jiarui,SUN Hongbing,et al.Effects of thalidomide on secretion of TNF-α and VEGF in fibroblast-like synoviocytes and peripheral blood mononuclear cells in patients with rheumatoid arthritis and its mechanism[J].,2022,51(12):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
[8]王小蕊,李文倩,解友邦,等.托法替尼联合传统DMARDs类药物治疗类风湿性关节炎临床效果观察[J].陕西医学杂志,2023,52(12):1728.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]
WANG Xiaorui,LI Wenqian,XIE Youbang,et al.Clinical effect of tofacitinib combined with traditional DMARDs in treatment of rheumatoid arthritis[J].,2023,52(12):1728.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]
[9]王一晨,谷慧敏,陈宇华,等.孟德尔随机化在类风湿关节炎相关研究中的应用[J].陕西医学杂志,2024,(11):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
WANG Yichen,GU Huimin,CHEN Yuhua,et al.Application of Mendelian randomization in rheumatoid arthritis-related research[J].,2024,(12):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
[10]康 聪,杨 光,王 芳,等.牛膝多糖调控转移相关蛋白1/核因子-κB通路对类风湿关节炎大鼠踝关节破坏的影响实验研究[J].陕西医学杂志,2024,(12):1624.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.007]
KANG Cong,YANG Guang,WANG Fang,et al.Effects of achyranthan polysaccharides regulating MTA1/NF-κB pathway on destruction of ankle joint in rats with rheumatoid arthritis[J].,2024,(12):1624.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.007]